Abstract
Butantan Institute is nowadays the main producer of Influenza vaccine in the Southern Hemisphere, with the challenge of achieving national autonomy by increasing the capacity of production of the Flu vaccine. Therefore, influenza vaccines in development such as the quadrivalent seasonal, adjuvanted formulations, high dose and pre-pandemic H5Nx vaccines are under assessement. Not only Infl…